Our Services
FDA Regulatory & Compliance Services for Pharma, Biotech & Healthcare
Success in today’s fast‑moving biopharmaceutical environment requires proactive regulatory strategy and continuous inspection readiness. XFDA Pharma Advisors delivers end‑to‑end pharmaceutical compliance consulting — backed by decades of FDA and industry expertise — supporting clients from early development through regulatory submissions, approval, and post‑market FDA compliance. Our approach emphasizes data integrity, effective audit and compliance practices, and strong quality system oversight (QMS) to ensure sustainable success in highly regulated markets.
FDA 483 & Warning Letter Response and Remediation
- CGMP Audits and FDA/EMA inspection readiness
- Responses to FDA Form 483 and Warning Letters
- Independent 3rd party assessment and oversight
- Addressing CRLs
- Discipline Review Letter (DRL)
- CGMP compliance
- Inspection readiness activities
- SMEs coaching, backroom and front room management
- QMS development and implementation
- Product and process validation
- Internal and corporate auditing management and execution
- Cultural and organizational change initiatives
- 503B audits and compliance
- Due diligence audit
- Data integrity assessment and remediation
- Root cause analysis and critical thinking
- Supplier controls and CMO management (including inspection readiness)
- Comprehensive ANDA, NDA and CMC review
- Mock PAI and surveillance inspections
- 6 system comprehensive baseline assessment
- Manufacturing and laboratory oversight
- Comprehensive remediation plans
- Training and personnel development
- Pre-License Inspection (PLIs)
- And More…..
Inspection Readiness & Mock FDA Inspections
We help sponsors and manufacturers build business‑aligned regulatory strategies for approvals and market continuity. Our pharmaceutical compliance consulting strengthens audits, ensures data integrity, streamlines submissions, and aligns with CGMP and QMS standards.
- Regulatory strategies tailored to your product and lifecycle stage, ensuring the right priorities at the right time.
- CMC section preparation and gap analysis for IND/NDA/ANDA/BLA submissions.
- Dossier development and support for regulatory meetings and agency communications.
- Cross-discipline review of comparability, analytical data, microbiology, and sterility assurance.
CGMP & GxP Audits
A single CGMP gap can stall an approval by months. Our audits are built to catch those gaps before an inspector does — covering everything from documentation practices to sterile manufacturing controls.
- In-situ mock inspections and full pre-approval inspection simulations to ensure readiness and confidence.
- On-site, remote, and post-audit support to strengthen outcomes and ensure sustained compliance.
- Practical, role-based training for leadership and operations teams — building real-world preparedness and strong inspection readiness.
- Targeted remediation, FDA 483/Warning Letter responses, and risk-based compliance improvements.
- Flexible support for pre-, during-, and post-inspection needs.
Expert guidance in global standards with API and sterile manufacturing compliance. Our pharmaceutical consulting strengthens CGMP, supports inspection readiness, ensures data integrity, and aligns with FDA/EMA expectations for sustainable success.
Regulatory Strategy, Submissions & CMC Review
We conduct comprehensive GxP audits to support compliance across global markets:
- Mock PAI and pre-approval audits to ensure FDA-ready operations.
- For-cause and independent investigations to close compliance gaps and reinforce CGMP control.
- Due diligence and vendor audits to ensure compliant and reliable CGMP partners.
- Routine readiness audits to maintain compliance and prepare for regulatory inspections.
- CMO audits and lab oversight to ensure strong CGMP compliance across partners.
We work across sterile products, biologics, oral solids, transdermals, liquids and creams, APIs, excipients, and supplements — so whatever your platform, our audit approach is built around how FDA actually inspects it.
QMS Design, Validation & Data Integrity
Remediation is resource‑intensive and demands disciplined execution. We lead corrective actions to ensure lasting CGMP compliance, strengthen audits, safeguard data integrity, and support robust QMS oversight for sustainable improvement.
- FDA 483 and Warning Letter response support — ensuring clear, compliant remediation.
- Independent reviews of records and data to detect gaps and improve CGMP compliance.
- Interpreting FDA action levels (OAI, VAI) and defining targeted, effective response strategies.
- Independent manufacturing and lab oversight, including CGMP-aligned product release support.
- CAPA development, tracking, and effectiveness checks to ensure lasting compliance.
- Preparation and support for regulatory meetings to ensure clear communication and aligned compliance strategies.
CGMP & Compliance Training
We design and implement systems that strengthen CGMP compliance, drive inspection readiness, safeguard data integrity, and streamline regulatory submissions for sustainable success in regulated markets.
- QMS design and implementation for new or expanding product areas — ensuring scalable compliance.
- Validation and qualification protocols (DQ/IQ/OQ/PQ) for compliant equipment, processes, and software.
- Process and computer software validation support to maintain reliable, CGMP-aligned operations.
- ANDA/NDA compliance reviews and system enhancements based on internal assessments and third-party audit findings.
Specialized Training Programs
Our training programs go beyond the basics — covering everything from OOS/OOT investigations to nitrosamine risk assessment and internal auditor certification. Delivered on-site or virtually, and tailored to your team’s role and experience level.
- CGMP fundamentals and advanced training to strengthen compliance awareness and operational excellence.
- Data integrity training focused on assessments, remediation, and maintaining secure, compliant records.
- OOS/OOT investigations and root-cause analysis training to improve decision-making and investigation quality.
- Nitrosamine risk assessment
- Contamination control and aseptic technique training to reinforce sterile operations and prevent quality risks.
- Internal auditor development and certification training to build strong CGMP audit capability.
- FDA inspection preparedness training to build confidence and ensure smooth inspections.
- CAPA, investigation, and nonconformance management training to strengthen corrective actions and compliance control.
Value & Benefits
- Reputation: Strong inspection readiness and successful mock audits demonstrate commitment to quality and build stakeholder confidence.
- Cost avoidance: Proactive readiness helps prevent costly compliance issues, rework, and recalls.
- Practical outcomes: We turn regulatory expectations into sustainable systems and practices that protect product quality and business continuity.
Talk to an Expert About Your Inspection, 483 or Submission
Whether preparing for an FDA submission or strengthening quality systems, our experts are ready to help. Connect with us for tailored CGMP compliance consulting that ensures inspection readiness, supports accurate regulatory submissions, and upholds data integrity through trusted pharmaceutical compliance consulting practices.